PATENT CLAIM ANALYSIS

Application Number: 15751134
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["424", "085200"]

Abstract:
Methods of treating subjects having a cancer-related disease, disorder, or condition, or preventing the occurrence of such a disease, disorder or condition, via the administration of a PEG-IL-10 agent in combination with an IL-15 agent are provided.

Claim (Index 36):
The method of  claim 1 , wherein the effects of the PEG-IL-10 and the IL-15 agent are synergistic.

Metadata:
- Claim Count in Document: 126.0
- Percentile: 88.0
- Lexical Diversity: 1.53571
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15513825', '15543949', '14908992', '14779929', '15328882']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7027572345273416
- 35 USC 102 Novelty (BERT): 0.5343131235503269
- Combined Prediction Score: 0.6859128234296402
- Mean Citation Score: 325.5789660000001
- Max Citation Score: 340.58798
- Similarity Product: 239.03876976663352

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test